Tumour markers of prognosis in colorectal cancer
Open Access
- 18 December 1998
- journal article
- research article
- Published by Springer Science and Business Media LLC in British Journal of Cancer
- Vol. 79 (2), 191-203
- https://doi.org/10.1038/sj.bjc.6690033
Abstract
No abstract availableThis publication has 107 references indexed in Scilit:
- PROGNOSTIC SIGNIFICANCE OF p53 ABNORMALITIES IN COLORECTAL CARCINOMA DETECTED BY PCR-SSCP AND IMMUNOHISTOCHEMICAL ANALYSISThe Journal of Pathology, 1996
- "Clinicopathologic and Prognostic Significance of an Angiogenic Factor, Thymidine Phosphorylase, in Human Colorectal Carcinoma"JNCI Journal of the National Cancer Institute, 1996
- C-KI-RAS activation and the biological behaviour of proximal and distal colonic adenocarcinomasEuropean Journal Of Cancer, 1996
- ras and p53 in the prediction of survival in Dukes' stage B colorectal carcinomaMolecular Pathology, 1995
- Tumour suppressors, kinases and clamps: How p53 regulates the cell cycle in response to DNA damageBioEssays, 1995
- Cyclin/proliferation cell nuclear antigen immunohistochemistry does not improve the prognostic power of Dukes' or Jass' classifications for colorectal cancerBritish Journal of Surgery, 1995
- c‐erbB‐2 oncoprotein in relation to DNA ploidy and prognosis in colorectal adenocarcinomaAPMIS, 1995
- The common molecular genetic alterations in Dukes' B and C colorectal carcinomas are not short‐term prognostic indicators of survivalInternational Journal of Cancer, 1994
- Urokinase-type plasminogen activator and outcome in Dukes' B colorectal cancerThe Lancet, 1994
- ras p21 expression in relation to DNA ploidy, S-phase fraction and prognosis in colorectal adenocarcinomaEuropean Journal of Cancer and Clinical Oncology, 1991